Comments*

 
  • Events 

    Tuesday, July 28, 2015 | 8:30 AM - 6:00 PM

    Leveraging Big Data and Predictive Knowledge to Fight Disease

    Speakers: Marc D Chioda (Pfizer Inc), Leonard James (Pfizer Inc), Iya Khalil (GNS Healthcare), Michael Matheny (Vanderbilt University), Jason H. Moore (University of Pennsylvania), Nicholas Tatonetti (Columbia University Medical Center), Craig P. Webb (NuMedii, Inc), Chunhua Weng (Columbia University)

    In the era of precision medicine, analyses of large volumes of data are key to developing targeted and effective therapeutics. This symposium explores how big data and predictive knowledge are used to guide drug development and clinical trials.

    October 18 - 22, 2015

    Tenth Cooley's Anemia Symposium

    Keynote Speakers: Maria Domenica Cappellini (University of Milan) and Stuart H. Orkin (Boston Children's Hospital and Dana-Farber Cancer Institute)
    Speakers: Emanuele Angelucci (Cancer Hospital "Armando Businco," Cagliari), Jodie L. Babitt (Massachusetts General Hospital), Jonathan M. Barasch (Columbia University), Daniel E. Bauer (Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School), Sunil Bhandari (Hull and East Yorkshire Hospitals NHS Trust and Hull York Medical School), Caterina Borgna-Pignatti (University of Ferrara), Farid Boulad (Memorial Sloan-Kettering Cancer Center), Marina Cavazzana-Calvo (Hospital Necker, University Paris Descartes), David H.K. Chui (Boston University School of Medicine), Thomas D. Coates (Childrens Hospital Los Angeles, University of Southern California Keck School of Medicine), Ann Dean (National Institutes of Health), David Dinan (Nemours Children’s Hospital), Alexander (Hal) Drakesmith (Radcliffe Department of Medicine, University of Oxford), Kathleen Durst (Cooley's Anemia Foundation), Giuliana Ferrari (San Raffaele-Telethon Institute for Gene Therapy), Steven Flamm (Northwestern Medical Center), Mark D. Fleming (Boston Children's Hospital), Ellen B. Fung (UCSF Benioff Children's Hospital Oakland), Andrea Giusti (Galliera Hospital), Olivier Hermine (Hospital Necker, University Paris Descartes), Doug Higgs (University of Oxford), Eldad Arie Hod (Columbia University), Janet L. Kwiatowski (The Children's Hospital of Philadelphia; Perelman School of Medicine, University of Pennsylvania), Ashutosh (Ash) Lal (University of California San Francisco Benioff Children’s Hospital Oakland), Roberto Machado (University of Illinois College of Medicine), Punam Malik (Cincinnati Children’s Hospital), Jeffery L. Miller (National Institute of Diabetes and Digestive and Kidney Diseases), David G. Nathan (Dana-Farber Cancer Institute),  Elizabeth (Ella) Nemeth (University of California, Los Angeles), Ellis Neufeld (Boston Children's Hospital), Arthur Nienhuis (St. Jude Children's Research Hospital), Dudley Pennell (Imperial College London), Antonio Piga (Torino University), John Porter (University College London Hospitals), Stefano Rivella (Weill Cornell Medical Center), Thomas M. Ryan (The University of Alabama at Birmingham), Vijay Sankaran (Boston Children's Hospital and Dana-Farber Cancer Institute), Shalini Shenoy (St. Louis Children's Hospital),  Ali Taher (American University of Beirut Medical Center), Swee Lay Thein, John F. Tisdale (National Heart, Lung, and Blood Institute), Suzy V. Torti (University of Connecticut Health Center), Tim M. Townes (The University of Alabama at Birmingham), Marsha J. Treadwell (Children's Hospital Oakland), Vip Viprakasit (Siriraj Hospital, Mahidol University), John C. Wood (Children's Hospital Los Angeles)

    Global experts explore the biology of globin gene regulation and fetal hemoglobin induction; stem cell transplant, gene therapy strategies, and gene editing; and clinical issues in thalassemia treatment and imaging.

    Tuesday, October 27, 2015 | 8:30 AM - 5:00 PM

    Phenotypic and Biomarker-Based Drug Discovery

    Speakers: Andras Bauer (Boehringer Ingelheim), Alex Huang (Genentech), Bryan Laffitte (Genomics Institute of the Novartis Research Foundation), Jonathan Lee (Eli Lilly ), Lorenz Mayr (AstraZeneca), Aravind Subramanian (Broad Institute), Giulio Superti-Furga (Austrian Academy of Sciences), Robert Temple (US Food and Drug Administration )

    This symposium aims to deepen our understanding of phenotypic drug discovery and to foster the exchange of ideas between industry-based and academic research scientists.

  • Past Events

    Friday, June 19, 2015 | 8:00 AM - 5:30 PM

    Microbes in the City:
    Mapping the Urban Genome

    Speakers: Joel Ackelsberg (NYC Department of Health and Mental Hygiene), Eric Alm (Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology), Martin J. Blaser (New York University Langone Medical Center), Ilana Brito (Massachusetts Institute of Technology), Jane Carlton (New York University Center for Genomics and Systems Biology), Rumi Chunara (New York University Polytechnic School of Engineering), Laurie Garrett (Council on Foreign Relations), Jack Gilbert (Argonne National Laboratory), Jo Handelsman (White House Office of Science and Technology Policy), Curtis Huttenhower (Harvard T.H. Chan School of Public Health), W. Ian Lipkin (Center for Infection and Immunity, Columbia University), Juan Maestre (The University of Texas at Austin), Christopher Mason (Institute for Computational Biomedicine, Weill Cornell Medical College), Paula Olsiewski (Alfred P. Sloan Foundation), Rachel Poretsky (University of Illinois at Chicago), Coby Schal (North Carolina State University Department of Entomology)

    Efforts to map all of the genetic information of microbial communities that make up the urban genome—from kiosks and subways, to soil and sewage—seek to improve the health and productivity of the built environments in which we live.

    Thursday, June 18, 2015 | 8:00 AM - 5:30 PM

    Quantitative Biology:
    From Molecules to Man

    Keynote Speaker: Steve Kay (University of Southern California)
    Speakers: Francis J. Doyle III (University of California Santa Barbara), Andrew Ewald, PhD (Johns Hopkins University), Scott E. Fraser (University of Southern California), Peter Kuhn (University of Southern California), Christopher E. Mason (Weill Cornell Medical College), Paul Newton (University of Southern California), Amanda Randles (Harvard University), Chris Sander (Memorial Sloan Kettering Cancer Center)

    Quantitative Biology: From Molecules to Man will bring together professionals in science, medicine, and engineering to articulate a vision for the future of improving patient health outcomes.

    Monday, June 1, 2015 | 1:30 PM - 4:30 PM

    Genome Integrity Discussion Group Meeting

    Keynote Speaker: Anne Villeneuve (Stanford University)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

    Monday, April 27, 2015 | 8:30 AM - 4:45 PM

    Non-Motor Symptoms: Unraveling the "Invisible" Face of Parkinson’s Disease

    Speakers: Erwan Bezard (University of Bordeaux), Patrik Brundin (Van Andel Institute), Marie-Francoise Chesselet (UCLA), Diane G. Cook (Parkinson's Disease Foundation), Maurizio Facheris (The Michael J. Fox Foundation for Parkinson's Research), Horacio Kaufmann (NYU Langone Medical Center), Olivier Rascol (University of Toulouse), Anna Sauerbier (NPF International Centre of Excellence, Kings College London), Daniel Weintraub (University of Pennsylvania)

    This symposium will review clinical tools for the diagnosis and treatment of non-motor symptoms of Parkinson's disease, discuss the disease mechanisms, and address preclinical models for the development of new therapeutics.